Vanda Pharmaceuticals develops and commercializes pharmaceutical products for the treatment of central nervous system disorders.
Business Model:
Revenue: $257.9M
Employees: 201-500
Address: 2200 Pennsylvania Ave NW
City: Washington
State: district of columbia
Zip: 20037
Country: US
Vanda Pharmaceuticals develops and commercializes pharmaceutical products for the treatment of central nervous system disorders.
Contact Phone:
+12027343400
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/12/2006
Ticker Symbol:
VNDA
IPO Price:
$10/share
Amount Raised:
$58M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2014 | Post-IPO Equity | $54M | 3/2018 | Post-IPO Equity | $93.5M | 8/2013 | Post-IPO Equity | $48.3M | 4/2006 | IPO | $57.5M |
|
10/2007 | Post-IPO Debt | $100M | 10/2004 | Series B | 2 | $18.5M |
Prospect Venture Partners Domain Associates Prospect Venture Partners Domain Associates |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|